πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors β€” phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β€” searchable for business development and competitive intelligence.

2,762 results for β€œCTI” Clear

  1. Kenacort-A 10, suspensie voor injectie 10 mg/ml, Kenacort-T 40 mg/ml injektionsvΓ€tska, suspension

    Disc Medicine

    Strictures after esophageal atresia repair

    approved small molecule active

    1 trial
  2. Kenacort-A 40, suspensie voor injectie 40 mg/ml, Jyseleca 200 mg film-coated tablets

    Disc Medicine

    Rheumatoid arthritis

    approved small molecule active

    1 trial
  3. Kesimpta 20 mg solution for injection in pre-filled syringe

    Novartis Pharmaceuticals

    Relapsing forms of Multiple Sclerosis (RMS)

    approved small molecule active

    1 trial
  4. Ketorolac Injection

    United Therapeutics Europe Ltd

    Orthopaedic Trauma

    approved small molecule active

    1 trial
  5. Keverprazan

    The First People's Hospital of Lianyungang

    H. Pylori Infection

    approved small molecule active

    1 trial
  6. Kineret 100 mg/0.67 ml solution for injection in pre-filled syringe.

    Disc Medicine

    autoimmune disorders, joint disorders synonym: Still's disease, systemic JIA

    approved small molecule active

    1 trial
  7. Klisyri 10 mg/g ointment, Solaraze 30 mg/g Gel

    Almirall, S.A.

    Actinic Keratosis

    approved small molecule active

    1 trial
  8. L. helveticus R0052 and B. longum R0175

    Acadia Pharmaceuticals B.V.

    Attention Deficit Hyperactivity Disorder

    approved other active

    1 trial
  9. LIVTENCITY 200 mg film-coated tablets.

    The George Institute

    Transplant patients with high recurrent Epstein-Barr infection

    approved small molecule active

    1 trial
  10. Lansoprazole

    Takeda

    Functional Dyspepsia

    approved small molecule terminated

    1 trial
  11. Lantus 100 units/ml solution for injection in a cartridge, Lantus 100 units/ml solution for injection in a vial, Toujeo 300 units/ml DoubleStar, solution for injection in a pre-filled pen, Awiqli 700 units/mL solution for injection in pre-filled pen, Levemir FlexPen 100 units/ml solution for injection in pre-filled pen., Toujeo 300 units/ml DoubleStar, solution for injection in a pre-filled pen, Tresiba 200 units/mL FlexTouch solution for injection in pre-filled pen, Tresiba 100 units/mL FlexTouch solution

    NovoThirteen

    Type 2 diabetes

    approved small molecule active

    1 trial
  12. Levocarnitine Injection

    The First People's Hospital of Lianyungang

    Renal Dialysis

    approved small molecule completed

    1 trial
  13. Levofloxacin

    Hospital Authority, Hong Kong

    Urinary Tract Infection

    approved small molecule active

    1 trial
  14. Lisdexamfetamine dimesylate

    Takeda

    Attention-deficit/Hyperactivity Disorder

    approved small molecule completed

    3 trials
  15. Lisdexamfetamine dimesylate

    Takeda

    Attention Deficit Hyperactivity Disorder (ADHD)

    approved small molecule completed

    1 trial
  16. Live Combined Bifidobacterium and Lactobacillus

    The First People's Hospital of Lianyungang

    Functional Constipation

    approved small molecule active

    1 trial
  17. Low intensity laser for oral mucositis

    Lxo Ireland Designated Activity Company

    Oral Mucositis

    approved other active

    1 trial
  18. Low-Molecular-Weight Heparins Calcium Injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Pneumonia

    approved small molecule completed

    1 trial
  19. MAXIGRA, 100 mg, tabletki powlekane

    Lacuna Pharma Pty Ltd

    Erectile dysfunction

    approved small molecule active

    1 trial
  20. Mayzent 0.25 mg film-coated tablets, Mayzent 2 mg film-coated tablets, Mayzent 1 mg film-coated tablets, BAF312, BAF312, BAF312

    Verona Pharma Ireland Limited

    Active progressive multiple sclerosis course after an initial relapse clinical course

    approved small molecule active

    1 trial
  21. Methotrexate 2,5 mg film-coated tablets, Simponi 50 mg solution for injection in pre-filled syringe., Hydroxychloroquine sulfate 200mg film-coated Tablets, Cimzia 200 mg solution for injection in pre-filled syringe, Depo-Medrol 80 mg/2 ml Injektionssuspension, Leflunomide Aurobindo 20 mg compresse rivestite con film, Enbrel 50 mg solution for injection in pre-filled syringe, Humira 40 mg solution for injection in pre-filled syringe, Sulfasalazine 500 mg Tablets, Jyseleca 200 mg film-coated tablets, Kenacort

    Disc Medicine

    Rheumatoid arthritis according to 2010 criteria

    approved small molecule active

    1 trial
  22. Metronidazole

    Hospital Authority, Hong Kong

    Helicobacter Pylori Infection

    approved small molecule completed

    1 trial
  23. Morfina cloridrato S.A.L.F. 10 mg/ml soluzione iniettabile, ROPIVACAINA CLORIDRATO BIOINDUSTRIA L.I.M. 10 mg/ml soluzione iniettabile, CATAPRESAN 150 microgrammi/ml soluzione iniettabile

    Istituto Gentili S.r.l.

    cesarean section

    approved small molecule active

    1 trial
  24. Morphine

    COLLEGIUM PHARMACEUTICAL, INC

    ST-segment Elevation Myocardial Infarction

    approved small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β€” verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources